Excess Tax Benefits from Share-Based Compensation
HCA Healthcare Excess Tax Benefits from Share-Based Compensation remained flat by 0.0% to -$13.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.6%, from -$22.75M to -$13.75M. Over 2 years (FY 2023 to FY 2025), Excess Tax Benefits from Share-Based Compensation shows an upward trend with a -19.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates higher employee stock performance or increased exercise activity, leading to lower cash taxes paid.
Detailed definition
This represents the tax savings realized when the actual tax deduction from employee stock option exercises or restricte...
Peer comparison
Commonly reported by large-cap companies with significant equity-based compensation plans.
tmo_excess_tax_benefits_share_based_compensationHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | -$84.00M | -$91.00M | -$55.00M |
| YoY Change | — | -8.3% | +39.6% |
Excess Tax Benefits from Share-Based Compensation at Other Companies
Frequently Asked Questions
- What is HCA Healthcare's excess tax benefits from share-based compensation?
- HCA Healthcare (HCA) reported excess tax benefits from share-based compensation of -$13.75M in Q4 2025.
- How has HCA Healthcare's excess tax benefits from share-based compensation changed year-over-year?
- HCA Healthcare's excess tax benefits from share-based compensation increased by 39.6% year-over-year, from -$22.75M to -$13.75M.
- What is the long-term trend for HCA Healthcare's excess tax benefits from share-based compensation?
- Over 2 years (2023 to 2025), HCA Healthcare's excess tax benefits from share-based compensation has grown at a -19.1% compound annual growth rate (CAGR), from -$84.00M to -$55.00M.
- What does excess tax benefits from share-based compensation mean?
- The tax savings generated when employees exercise stock options at prices higher than the grant value.